Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
about
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinTNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice.Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in miceDNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in miceFunctional disruption of human leukocyte antigen II in human embryonic stem cellDC targeting DNA vaccines induce protective and therapeutic antitumor immunity in mice.Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
P2860
Q28537820-CE8EE8AF-9815-46B2-8E58-2526CD848372Q33729725-7A8148B0-7434-4228-A4CA-956F88B79007Q33730717-F01453E1-C578-490A-93FB-5A14BDECE0BBQ33842422-82793128-DB67-4EBF-820E-50FA12C1D5CCQ34472125-84B28D25-F6B4-4B81-9852-ACEFECF813B7Q34939255-8AF19026-FCCB-4850-9FCB-FEDE616AE2C5Q36220235-D8B04CB4-F17F-49E9-9BB5-6CB5315D099FQ36411564-2B174194-1516-4FD8-B191-AB387A34E990Q38332777-9AD45885-2D6F-49C0-B380-E75435CCE9C1Q39038680-5D4C105D-D53C-45E1-825A-409FCF765934
P2860
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@en
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@nl
type
label
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@en
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@nl
prefLabel
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@en
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@nl
P2093
P50
P1433
P1476
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
@en
P2093
Huafeng Wei
Kexing Fan
P304
P356
10.1158/0008-5472.CAN-07-6051
P407
P577
2008-05-01T00:00:00Z